TapImmune to Present at 2017 Biotechnology Innovation Organization International Convention


2017 Biotechnology Innovation Organization International Convention

[/vc_column_text][vc_empty_space height=”8px”][vc_column_text]JACKSONVILLE, FLORIDA – June 14, 2017 – TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the development of immunotherapies targeting women’s cancers, today announced that Dr. Glynn Wilson, Chairman and CEO of TapImmune, will present at the 2017 Biotechnology Innovation Organization International Convention held on June 19-22 in San Diego.

 

Date:    Tuesday, June 20, 2017
Time:    3:30 PM (Pacific Time)
Location:   Theater 2, San Diego Convention Center, San Diego, CA

[/vc_column_text][vc_empty_space height=”25px”][vc_column_text][pr-disclaimer]